Based on the above findings, we explored whether a NAMPT-dependent profile comprising Nampt, CD44, Jun, TEAD4, CSNK1A1, ABCC3, Serpine1 and HES1 enables correct stratification of glioblastoma patients. This evidence concerns the gene ABCC3 and glioblastoma.